Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third-party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.8. Commodity Flow Analysis
1.9. Approach: Commodity Flow Approach
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Objective
1.13. Objective 1
1.14. Objective 2
1.15. Objective 3
1.16. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Castrate-Resistant Prostate Cancer Market Variables, Trends & Scope
3.1. Castrate-Resistant Prostate Cancer Market Lineage outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. User Perspective Analysis
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.1.1. Rising prevalence of castrate-resistant prostate cancer
3.5.1.2. Increasing technological advancements
3.5.1.3. Rising adoption of treatment
3.5.2. Market restraint analysis
3.5.2.1. Lack of standard therapy
3.6. Castrate-Resistant Prostate Cancer Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
Chapter 4. Castrate-Resistant Prostate Cancer Market: Therapy Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Therapy Market Share Analysis, 2019 & 2027
4.3. Therapy Dashboard
4.4. Castrate-Resistant Prostate Cancer Market, By Therapy, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
4.5.1. Chemotherapy
4.5.1.1. Chemotherapy market, 2016 - 2027 (USD Million)
4.5.2. Hormonal Therapy
4.5.2.1. Hormonal therapy market, 2016 - 2027 (USD Million)
4.5.3. Immunotherapy
4.5.3.1. Immunotherapy market, 2016 - 2027 (USD Million)
4.5.4. Radiotherapy
4.5.4.1. Radiotherapy market, 2016 - 2027 (USD Million)
Chapter 5. Castrate-resistant Prostate Cancer Market: Segment Analysis, By Region, 2016 - 2027 (USD Million)
5.1 Castrate-resistant Prostate Cancer Market, Market Share by Region, 2019 & 2027
5.1.1 North America
5.1.1.1 North America market estimates and forecast, 2015 - 2027 (USD Million)
5.1.1.2 U.S.
5.1.1.2.1 U.S. market estimates and forecast, 2015 - 2027 (USD Million)
5.1.1.3 Canada
5.1.1.3.1 Canada market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2 Europe
5.1.2.1 Europe market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.2 U.K.
5.1.2.2.1 U.K. market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.3 Germany
5.1.2.3.1 Germany market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.4 France
5.1.2.4.1 France market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.5 Spain
5.1.2.5.1 Spain market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.6 Italy
5.1.2.6.1 Italy market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.7 Russia
5.1.2.7.1 Russia market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3 Asia Pacific
5.1.3.1 Asia Pacific market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.2 Japan
5.1.3.2.1 Japan market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.3 China
5.1.3.3.1 China market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.4 India
5.1.3.4.1 India market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.5 South Korea
5.1.3.5.1 South Korea market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.6 Singapore
5.1.3.6.1 Singapore market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.7 Australia
5.1.3.7.1 Australia market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4 Latin America
5.1.4.1 Latin America market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.2 Brazil
5.1.4.2.1 Brazil market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.3 Mexico
5.1.4.3.1 Mexico market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.4 Argentina
5.1.4.4.1 Argentina market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6 Middle East and Africa
5.1.6.1 Middle East & Africa market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.2 South Africa
5.1.6.2.1 South Africa market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.3 UAE
5.1.6.3.1 UAE market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.4 Saudi Arabia
5.1.6.4.1 Saudi Arabia market estimates and forecast, 2015 - 2027 (USD Million)
Chapter 6. Company Profiles
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Public Companies
6.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.3.2. Competitive dashboard analysis
6.3.3. Market differentiators
6.4. Private Companies
6.5. Company Profiles
6.5.1. Sanofi
6.5.1.1. Company Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Johnson & Johnson Services Inc.
6.5.2.1. Company Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Pfizer Inc.
6.5.3.1. Company Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. Astellas Pharma, Inc.
6.5.4.1. Company Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. Bayer AG
6.5.5.1. Company Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives



List of Tables



TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Castrate-resistant Prostate Cancer Market, By Region, 2016 - 2027 (USD Million)
TABLE 5 Global Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 6 North America Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 7 North America Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 8 U.S. Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 9 Canada Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 10 Europe Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 11 Europe Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 12 U.K. Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 13 Germany Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 14 France Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 15 Spain Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 16 Italy Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 17 Russia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 18 Asia Pacific Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 19 Asia Pacific Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 20 China Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 21 Japan Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 22 India Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 23 South Korea Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 24 Singapore Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 25 Australia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 26 Latin America Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 27 Latin America Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 28 Brazil Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 29 Mexico Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 30 Argentina Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 31 MEA Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 32 MEA Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 33 South Africa Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 34 UAE Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 35 Saudi Arabia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)